A $1 billion bet on AI-driven medicine AI chip leader Nvidia and pharmaceutical giant Eli Lilly announced a joint $1 billion investment to build a new artificial intelligence–focused drug discovery lab in San Francisco. The lab will be funded over

A New Push Toward Oral Weight-Loss Treatments AI meets metabolic medicine Nimbus Therapeutics announced a new research and licensing agreement with Eli Lilly to develop next-generation, AI-driven oral treatments for obesity and other metabolic diseases. Under the deal: The collaboration

Pfizer Lowers Earnings Outlook for 2026 Pfizer signaled continued pressure on its post-pandemic business, forecasting 2026 profit below analyst expectations as demand for COVID-related products continues to normalize. The drugmaker said it expects adjusted earnings of $2.80 to $3.00 per

Eli Lilly Becomes the First Health-Care Company to Hit $1 Trillion Eli Lilly has officially joined one of the most exclusive clubs in global markets, becoming the first health-care company in history to reach a $1 trillion valuation. Shares briefly

Novo Nordisk Lowers Cash-Pay Prices for Wegovy and Ozempic Novo Nordisk announced on Monday that it is reducing the direct-to-consumer monthly price of Wegovy and Ozempic to $349 for existing cash-paying patients, down from $499. The company said the highest

Amazon Pushes Deeper Into Healthcare Amazon has unveiled a new healthcare initiative: prescription vending kiosks inside One Medical clinics across Los Angeles. The system brings pharmacy services directly to the doctor’s office — a model designed to eliminate extra trips

Eli Lilly Expands U.S. Manufacturing Footprint Eli Lilly (LLY) announced plans to build a $6.5 billion manufacturing facility in Houston, Texas, as the company accelerates its push into obesity and cardiometabolic treatments. The site will focus on producing small molecule